Israel AI for Predicting Pandemics and Global Health Emergencies Market - Forecasts From 2025 To 2030

Description

Israel AI for Predicting Pandemics and Global Health Emergencies Market is anticipated to expand at a high CAGR over the forecast period.

Israel AI for Predicting Pandemics and Global Health Emergencies Market Key Highlights

• The Israeli government's National AI Program, which prioritizes AI integration in the public sector and healthcare, directly stimulates demand for deployable AI solutions in public health agencies.
• The market's supply chain is heavily dependent on intangible assets—specialized AI/ML talent and high-quality, long-term, and secure patient data, such as that maintained by Israel's HMOs.
• Regulatory frameworks from the Israeli Ministry of Health (MOH), such as the "Key Principles for Evaluating AI-Driven Interventional Trials" published in late 2024, introduce clear pathways for clinical validation, thereby increasing confidence and market adoption for AI-based tools.
• Focus is shifting from general diagnostic AI to precision public health, exemplified by local research institutes creating personalized "digital twins" to predict individual health trajectories and, by aggregation, forecasting population-level disease trends.

The Israeli AI for Predicting Pandemics and Global Health Emergencies Market is characterized by the convergence of a world-leading high-tech ecosystem and a centralized, digitized national healthcare infrastructure. This unique synergy positions the nation as a global incubator for advanced health intelligence technologies. The market's central tenet is leveraging deep learning and natural language processing (NLP) to analyze disparate data streams—including electronic health records (EHR), epidemiological data, and open-source intelligence—to shift from reactive disease management to proactive threat forecasting and resource allocation. This strategic pivot is driven by the imperative to establish real-time surveillance capabilities that surpass traditional, lagging indicator models, creating an intrinsic demand for high-performance, clinically validated AI software and services.

________________________________________

Israel AI for Predicting Pandemics and Global Health Emergencies Market Analysis

Growth Drivers

The foundational driver is the national imperative to leverage existing, high-quality centralized patient data. Israel's HMOs maintain decades of comprehensive, longitudinal patient records, which provides an unmatched training and validation dataset for predictive algorithms, directly increasing demand for sophisticated Software solutions capable of mining and modeling this data. Furthermore, the explicit governmental push through the National AI Program fosters a favorable ecosystem and earmarked public sector funding, which translates into direct procurement demand from Government & Public Health Agencies for outbreak prediction and health trend forecasting services. This state-sponsored demand ensures a stable customer base for high-risk, high-reward AI development.

Challenges and Opportunities

A primary challenge remains the scarcity of specialized computational and epidemiological talent required to refine and operationalize complex AI models for public health, which acts as a constraint on the overall supply of cutting-edge Services. The key opportunity lies in expanding the application of existing, locally developed AI systems, initially designed for individual disease diagnosis, toward population-level risk assessment. Companies already operating in the clinical AI space can adapt their proven platforms (e.g., image analysis, patient triaging) to detect subtle, aggregated signals of emerging health threats, creating new demand in the Risk Assessment segment for existing technology providers.

Supply Chain Analysis

The supply chain for this market is dominated by the flow of data and specialized expertise rather than physical components. The primary production hubs are the research and development centers in major Israeli tech clusters (e.g., Tel Aviv, Haifa), which host the critical mass of AI engineers and medical informaticians. Logistical complexity revolves around secure data pipeline dependencies, specifically the secure, real-time integration of disparate data sources from hospitals, HMOs, and the Ministry of Health into a unified AI platform. The market exhibits a heavy dependency on high-performance cloud infrastructure and highly-skilled personnel for model maintenance and deployment, making the availability of top-tier Services the market's most constrained resource.

Government Regulations

________________________________________

In-Depth Segment Analysis

By Application: Outbreak Prediction & Detection

The Outbreak Prediction & Detection segment represents a critical and high-value application, fueled by the direct memory of recent global health crises and the subsequent push for national resilience. Its necessity is specifically driven by the imperative of Government & Public Health Agencies to achieve a predictive capability that exceeds simple epidemiological modeling. This requires solutions integrating machine learning with high-velocity, real-time data from non-traditional sources—including open-source intelligence and social media sentiment—beyond conventional clinical data. The market seeks sophisticated Software tools that can process unstructured data with advanced NLP and rapidly identify subtle spatial and temporal clusters of disease signals. This functionality reduces the critical lag time between initial infection and official reporting, creating a massive premium for systems that provide a genuine time advantage for policymakers to activate resource allocation protocols.

By End-User: Government & Public Health Agencies

The demand profile from Government & Public Health Agencies is centered on large-scale, enterprise-level AI deployments that ensure system-wide readiness and continuity of operations. Unlike point solutions for hospitals, the core growth driver here is the need for sophisticated Services that enable centralized population health management and resource optimization. This involves procuring not just the AI Software, but the essential integration and maintenance services to link systems like the Ministry of Health's repositories with various HMOs and local municipalities. The government is the primary purchaser of Risk Assessment and Public Health Resource Allocation applications, where the success metric is the system's ability to minimize the operational impact of a health crisis. This segment requires solutions with stringent security and compliance certifications, directly supporting the regulatory frameworks established by the MOH.

________________________________________

Competitive Environment and Analysis

The Israeli AI for public health market is intensely competitive, characterized by agile startups leveraging deep clinical expertise and proprietary access to high-quality healthcare data. Competition is segmented between companies providing diagnostic AI tools that can be repurposed for surveillance and those focusing purely on population health prediction. The market is not dominated by foreign technology giants, but rather by locally grown entities with deep integration into the Israeli healthcare system.

Aidoc

Aidoc is strategically positioned as a leader in clinical AI, primarily focusing on radiology workflow optimization. The company's competitive edge is its proprietary aiOS™ platform, which allows rapid deployment of multiple, certified AI applications directly into existing hospital Picture Archiving and Communication Systems (PACS) and Electronic Health Records (EHR). Aidoc's CARE™ Foundation Model, announced in collaboration with AWS in January 2025, represents a significant move toward scaling clinical-grade AI. While not strictly an outbreak prediction tool, its ability to identify incidental findings across diverse medical imaging modalities can be aggregated for epidemiological surveillance, positioning the company for potential expansion into macro-level Disease Surveillance by extending its model's scope.

Diagnostic Robotics

Diagnostic Robotics specializes in AI-driven patient navigation and triage, positioning itself at the front door of the healthcare system. The company's core strategy leverages a vast dataset of patient claims and medical records to predict medical events and guide patients to the appropriate care setting. Its competitive strength lies in using predictive AI to reduce physician burden and healthcare costs, as highlighted by customer results such as a fourfold cost savings compared to historical methodologies. This platform is inherently adaptable to early-stage Outbreak Prediction & Detection by analyzing mass patient inquiry trends for clusters of non-specific symptoms that signal an emerging public health threat, providing a pre-diagnostic surveillance layer for public health agencies.

________________________________________

Recent Market Developments

January 2025: Aidoc announced a Strategic Collaboration Agreement with Amazon Web Services (AWS) involving significant investment over multiple years. This partnership is focused on optimizing Aidoc's clinical-grade CARE™ Foundation Model to pioneer new standards in patient care. The collaboration aims to accelerate the development of new models to cover additional imaging modalities beyond X-rays and CT scans, positioning the company to scale its AI platform globally and advance the use of foundation models in healthcare. The strategic focus on a large-scale, adaptable foundation model provides the underlying technological architecture necessary to pivot toward population-level pattern detection.

September 2024: K Health, an Israeli-founded digital primary care startup, secured a partnership with Hackensack Meridian Health to deploy its AI-driven virtual primary care service. The partnership focuses on integrating K Health's AI to support hybrid primary care models, extending the reach of 24/7 care. This expansion of K Health's virtual care platform, which leverages proprietary AI to analyze medical records and provide diagnostic support, demonstrates an increased capacity for real-time aggregation of symptomatic data, which is a foundational requirement for mass-scale Health Trend Forecasting and early detection of localized outbreaks.

________________________________________

Israel AI for Predicting Pandemics and Global Health Emergencies Market Segmentation

• BY COMPONENT
  • Software
  • Services
  • Hardware
• BY DEPLOYMENT MODE
  • Cloud-based
  • On-Premises
• BY APPLICATION
  • Outbreak Prediction & Detection
  • Disease Surveillance
  • Contract Tracing
  • Risk Assessment
  • Health Trend Forecasting
  • Public Health Resource Allocation
  • Others
• BY END-USER
  • Government & Public Health Agencies
  • Hospitals & Clinics
  • Research Institutions
  • Pharmaceuticals and Biotech Companies
  • Academic Institutions
  • Others

Table Of Contents

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

2.1. Market Overview

2.2. Market Definition

2.3. Scope of the Study

2.4. Market Segmentation

3. BUSINESS LANDSCAPE

3.1. Market Drivers

3.2. Market Restraints

3.3. Market Opportunities

3.4. Porter's Five Forces Analysis

3.5. Industry Value Chain Analysis

3.6. Policies and Regulations

3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. ISRAEL AI FOR PREDICTING PANDEMICS AND GLOBAL HEALTH EMERGENCIES MARKET BY COMPONENT

5.1. Introduction

5.2. Software

5.3. Services

5.4. Hardware

6. ISRAEL AI FOR PREDICTING PANDEMICS AND GLOBAL HEALTH EMERGENCIES MARKET BY DEPLOYMENT MODE

6.1. Introduction

6.2. Cloud-based

6.3. On-Premises

7. ISRAEL AI FOR PREDICTING PANDEMICS AND GLOBAL HEALTH EMERGENCIES MARKET BY APPLICATION

7.1. Introduction

7.2. Outbreak Prediction & Detection

7.3. Disease Surveillance

7.4. Contract Tracing

7.5. Risk Assessment

7.6. Health Trend Forecasting

7.7. Public Health Resource Allocation

7.8. Others

8. ISRAEL AI FOR PREDICTING PANDEMICS AND GLOBAL HEALTH EMERGENCIES MARKET BY END-USER

8.1. Introduction

8.2. Government & Public Health Agencies

8.3. Hospitals & Clinics

8.4. Research Institutions

8.5. Pharmaceuticals and Biotech Companies

8.6. Academic Institutions

8.7. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

9.1. Major Players and Strategy Analysis

9.2. Market Share Analysis

9.3. Mergers, Acquisitions, Agreements, and Collaborations

9.4. Competitive Dashboard

10. COMPANY PROFILES

10.1. Aidoc

10.2. DayTwo

10.3. K Health

10.4. Diagnostic Robotics

10.5. Binah.ai

10.6. TytoCare

10.7. Medial EarlySign

10.8. Baze Technologies

10.9. Medialight

10.10. EarlySense

11. APPENDIX

11.1. Currency

11.2. Assumptions

11.3. Base and Forecast Years Timeline

11.4. Key benefits for the stakeholders

11.5. Research Methodology

11.6. Abbreviations

LIST OF FIGURES

LIST OF TABLES

Companies Profiled

Aidoc

DayTwo

K Health

Diagnostic Robotics

Binah.ai

TytoCare

Medial EarlySign

Baze Technologies

Medialight

EarlySense

Related Reports